
Dolby Laboratories (DLB) Stock Forecast & Price Target
Dolby Laboratories (DLB) Analyst Ratings
Bulls say
Dolby Laboratories Inc. reported total revenues of $307.0 million, reflecting a year-over-year increase of approximately 1%, aligning closely with expectations. The company's full-year operating margins improved to 33.2%, up from 31.2% in the previous year, and overall revenue rose by 5.9% driven primarily by a 5.6% increase in licensing revenue and a robust 10% growth in product and services. Additionally, the increasing adoption of its technologies, particularly in emerging markets like China and India, along with continued growth potential in premium cinema technologies, contributes to a positive outlook for the company's financial trajectory.
Bears say
Dolby Laboratories Inc. is projecting a decline in revenue for fiscal 2026, expecting a high-single-digit decrease, which aligns with similar trends observed in fiscal 2025. The company's revised growth forecast for its Atmos/Vision/Patents business is now 15% to 20%, down from a previous estimate of 15% to 25%, indicating potential stagnation in a critical segment. Additionally, gross margins are decreasing, currently at 89.7% compared to 90.1% the previous year, suggesting pressure on profitability amidst challenges in device volumes and a challenging macro environment.
This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.
Dolby Laboratories (DLB) Analyst Forecast & Price Prediction
Start investing in Dolby Laboratories (DLB)
Order type
Buy in
Order amount
Est. shares
0 shares